Matches in Nanopublications for { ?s ?p "[In conclusion the frequency of CSF3R mutations is highly prevalent among AML patients secondary to SCN compared to de novo AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP332250.RABDEXHvShSgtSWETQ4wMJ0BlyssxtChVTvztOyTmicGo130_assertion description "[In conclusion the frequency of CSF3R mutations is highly prevalent among AML patients secondary to SCN compared to de novo AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP332250.RABDEXHvShSgtSWETQ4wMJ0BlyssxtChVTvztOyTmicGo130_provenance.
- NP332128.RAW64j6f1lcnNiBz7rXyyy304CxL8urkVNOJVRlgF11RA130_assertion description "[In conclusion the frequency of CSF3R mutations is highly prevalent among AML patients secondary to SCN compared to de novo AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP332128.RAW64j6f1lcnNiBz7rXyyy304CxL8urkVNOJVRlgF11RA130_provenance.
- assertion description "[In conclusion the frequency of CSF3R mutations is highly prevalent among AML patients secondary to SCN compared to de novo AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In conclusion the frequency of CSF3R mutations is highly prevalent among AML patients secondary to SCN compared to de novo AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1174997.RA97TqV3-XACc8ikSyWbP4h2dBZOgNrP0dmm0FyJBR7PI130_assertion description "[In conclusion the frequency of CSF3R mutations is highly prevalent among AML patients secondary to SCN compared to de novo AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1174997.RA97TqV3-XACc8ikSyWbP4h2dBZOgNrP0dmm0FyJBR7PI130_provenance.
- NP1174999.RA_CWzIFw2U6XEzNU2EbcuI_9oj_GA4xsqu9tm2yz5B9Y130_assertion description "[In conclusion the frequency of CSF3R mutations is highly prevalent among AML patients secondary to SCN compared to de novo AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1174999.RA_CWzIFw2U6XEzNU2EbcuI_9oj_GA4xsqu9tm2yz5B9Y130_provenance.
- NP332209.RAvKyY4mma01TtKzrW9jPmA1OXH5teBTlhLrKYzy2wd7Y130_assertion description "[In conclusion the frequency of CSF3R mutations is highly prevalent among AML patients secondary to SCN compared to de novo AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP332209.RAvKyY4mma01TtKzrW9jPmA1OXH5teBTlhLrKYzy2wd7Y130_provenance.
- NP1174998.RAhAjXXkwn0Aep8zVStLxBfGrFXK-ELrQtaluzbsya1R4130_assertion description "[In conclusion the frequency of CSF3R mutations is highly prevalent among AML patients secondary to SCN compared to de novo AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1174998.RAhAjXXkwn0Aep8zVStLxBfGrFXK-ELrQtaluzbsya1R4130_provenance.